author_facet Chang, Pearl W.
Newman, Thomas B.
Chang, Pearl W.
Newman, Thomas B.
author Chang, Pearl W.
Newman, Thomas B.
spellingShingle Chang, Pearl W.
Newman, Thomas B.
Pediatrics
A Simpler Prediction Rule for Rebound Hyperbilirubinemia
Pediatrics, Perinatology and Child Health
author_sort chang, pearl w.
spelling Chang, Pearl W. Newman, Thomas B. 0031-4005 1098-4275 American Academy of Pediatrics (AAP) Pediatrics, Perinatology and Child Health http://dx.doi.org/10.1542/peds.2018-3712 <jats:sec> <jats:title /> </jats:sec> <jats:sec> <jats:title>OBJECTIVES:</jats:title> <jats:p>We previously reported a clinical prediction rule to estimate the probability of rebound hyperbilirubinemia using gestational age (GA), age at phototherapy initiation, and total serum bilirubin (TSB) relative to the treatment threshold at phototherapy termination. We investigated (1) how a simpler 2-variable model would perform and (2) the absolute rebound risk if phototherapy were stopped at 2 mg/dL below the threshold for treatment initiation.</jats:p> </jats:sec> <jats:sec> <jats:title>METHODS:</jats:title> <jats:p>Subjects for this retrospective cohort study were infants born 2012–2014 at ≥35 weeks’ gestation at 1 of 17 Kaiser Permanente hospitals who underwent inpatient phototherapy before age 14 days. TSB reaching the phototherapy threshold within 72 hours of phototherapy termination was considered rebound. We simplified by using the difference between the TSB level at the time of phototherapy termination and the treatment threshold at the time of phototherapy initiation as 1 predictor, and kept GA as the other predictor.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS:</jats:title> <jats:p>Of the 7048 infants treated with phototherapy, 4.6% had rebound hyperbilirubinemia. The area under the receiver operating characteristic curve was 0.876 (95% confidence interval, 0.854 to 0.899) for the 2-variable model versus 0.881 (95% confidence interval, 0.859 to 0.903) for the 3-variable model. The rebound probability after stopping phototherapy at 2 mg/dL below the starting threshold was 2.5% for infants ≥38 weeks’ GA and 10.2% for infants &amp;lt;38 weeks’ GA.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS:</jats:title> <jats:p>Rebound hyperbilirubinemia can be predicted by a simpler 2-variable model consisting of GA and the starting threshold–ending TSB difference. Infants &amp;lt;38 weeks’ gestation may need longer phototherapy because of their higher rebound risk.</jats:p> </jats:sec> A Simpler Prediction Rule for Rebound Hyperbilirubinemia Pediatrics
doi_str_mv 10.1542/peds.2018-3712
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTU0Mi9wZWRzLjIwMTgtMzcxMg
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTU0Mi9wZWRzLjIwMTgtMzcxMg
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint American Academy of Pediatrics (AAP), 2019
imprint_str_mv American Academy of Pediatrics (AAP), 2019
issn 0031-4005
1098-4275
issn_str_mv 0031-4005
1098-4275
language English
mega_collection American Academy of Pediatrics (AAP) (CrossRef)
match_str chang2019asimplerpredictionruleforreboundhyperbilirubinemia
publishDateSort 2019
publisher American Academy of Pediatrics (AAP)
recordtype ai
record_format ai
series Pediatrics
source_id 49
title A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_unstemmed A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_full A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_fullStr A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_full_unstemmed A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_short A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_sort a simpler prediction rule for rebound hyperbilirubinemia
topic Pediatrics, Perinatology and Child Health
url http://dx.doi.org/10.1542/peds.2018-3712
publishDate 2019
physical
description <jats:sec> <jats:title /> </jats:sec> <jats:sec> <jats:title>OBJECTIVES:</jats:title> <jats:p>We previously reported a clinical prediction rule to estimate the probability of rebound hyperbilirubinemia using gestational age (GA), age at phototherapy initiation, and total serum bilirubin (TSB) relative to the treatment threshold at phototherapy termination. We investigated (1) how a simpler 2-variable model would perform and (2) the absolute rebound risk if phototherapy were stopped at 2 mg/dL below the threshold for treatment initiation.</jats:p> </jats:sec> <jats:sec> <jats:title>METHODS:</jats:title> <jats:p>Subjects for this retrospective cohort study were infants born 2012–2014 at ≥35 weeks’ gestation at 1 of 17 Kaiser Permanente hospitals who underwent inpatient phototherapy before age 14 days. TSB reaching the phototherapy threshold within 72 hours of phototherapy termination was considered rebound. We simplified by using the difference between the TSB level at the time of phototherapy termination and the treatment threshold at the time of phototherapy initiation as 1 predictor, and kept GA as the other predictor.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS:</jats:title> <jats:p>Of the 7048 infants treated with phototherapy, 4.6% had rebound hyperbilirubinemia. The area under the receiver operating characteristic curve was 0.876 (95% confidence interval, 0.854 to 0.899) for the 2-variable model versus 0.881 (95% confidence interval, 0.859 to 0.903) for the 3-variable model. The rebound probability after stopping phototherapy at 2 mg/dL below the starting threshold was 2.5% for infants ≥38 weeks’ GA and 10.2% for infants &amp;lt;38 weeks’ GA.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS:</jats:title> <jats:p>Rebound hyperbilirubinemia can be predicted by a simpler 2-variable model consisting of GA and the starting threshold–ending TSB difference. Infants &amp;lt;38 weeks’ gestation may need longer phototherapy because of their higher rebound risk.</jats:p> </jats:sec>
container_issue 1
container_start_page 0
container_title Pediatrics
container_volume 144
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792340338028838918
geogr_code not assigned
last_indexed 2024-03-01T16:02:23.501Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+Simpler+Prediction+Rule+for+Rebound+Hyperbilirubinemia&rft.date=2019-07-01&genre=article&issn=1098-4275&volume=144&issue=1&jtitle=Pediatrics&atitle=A+Simpler+Prediction+Rule+for+Rebound+Hyperbilirubinemia&aulast=Newman&aufirst=Thomas+B.&rft_id=info%3Adoi%2F10.1542%2Fpeds.2018-3712&rft.language%5B0%5D=eng
SOLR
_version_ 1792340338028838918
author Chang, Pearl W., Newman, Thomas B.
author_facet Chang, Pearl W., Newman, Thomas B., Chang, Pearl W., Newman, Thomas B.
author_sort chang, pearl w.
container_issue 1
container_start_page 0
container_title Pediatrics
container_volume 144
description <jats:sec> <jats:title /> </jats:sec> <jats:sec> <jats:title>OBJECTIVES:</jats:title> <jats:p>We previously reported a clinical prediction rule to estimate the probability of rebound hyperbilirubinemia using gestational age (GA), age at phototherapy initiation, and total serum bilirubin (TSB) relative to the treatment threshold at phototherapy termination. We investigated (1) how a simpler 2-variable model would perform and (2) the absolute rebound risk if phototherapy were stopped at 2 mg/dL below the threshold for treatment initiation.</jats:p> </jats:sec> <jats:sec> <jats:title>METHODS:</jats:title> <jats:p>Subjects for this retrospective cohort study were infants born 2012–2014 at ≥35 weeks’ gestation at 1 of 17 Kaiser Permanente hospitals who underwent inpatient phototherapy before age 14 days. TSB reaching the phototherapy threshold within 72 hours of phototherapy termination was considered rebound. We simplified by using the difference between the TSB level at the time of phototherapy termination and the treatment threshold at the time of phototherapy initiation as 1 predictor, and kept GA as the other predictor.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS:</jats:title> <jats:p>Of the 7048 infants treated with phototherapy, 4.6% had rebound hyperbilirubinemia. The area under the receiver operating characteristic curve was 0.876 (95% confidence interval, 0.854 to 0.899) for the 2-variable model versus 0.881 (95% confidence interval, 0.859 to 0.903) for the 3-variable model. The rebound probability after stopping phototherapy at 2 mg/dL below the starting threshold was 2.5% for infants ≥38 weeks’ GA and 10.2% for infants &amp;lt;38 weeks’ GA.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS:</jats:title> <jats:p>Rebound hyperbilirubinemia can be predicted by a simpler 2-variable model consisting of GA and the starting threshold–ending TSB difference. Infants &amp;lt;38 weeks’ gestation may need longer phototherapy because of their higher rebound risk.</jats:p> </jats:sec>
doi_str_mv 10.1542/peds.2018-3712
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTU0Mi9wZWRzLjIwMTgtMzcxMg
imprint American Academy of Pediatrics (AAP), 2019
imprint_str_mv American Academy of Pediatrics (AAP), 2019
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 0031-4005, 1098-4275
issn_str_mv 0031-4005, 1098-4275
language English
last_indexed 2024-03-01T16:02:23.501Z
match_str chang2019asimplerpredictionruleforreboundhyperbilirubinemia
mega_collection American Academy of Pediatrics (AAP) (CrossRef)
physical
publishDate 2019
publishDateSort 2019
publisher American Academy of Pediatrics (AAP)
record_format ai
recordtype ai
series Pediatrics
source_id 49
spelling Chang, Pearl W. Newman, Thomas B. 0031-4005 1098-4275 American Academy of Pediatrics (AAP) Pediatrics, Perinatology and Child Health http://dx.doi.org/10.1542/peds.2018-3712 <jats:sec> <jats:title /> </jats:sec> <jats:sec> <jats:title>OBJECTIVES:</jats:title> <jats:p>We previously reported a clinical prediction rule to estimate the probability of rebound hyperbilirubinemia using gestational age (GA), age at phototherapy initiation, and total serum bilirubin (TSB) relative to the treatment threshold at phototherapy termination. We investigated (1) how a simpler 2-variable model would perform and (2) the absolute rebound risk if phototherapy were stopped at 2 mg/dL below the threshold for treatment initiation.</jats:p> </jats:sec> <jats:sec> <jats:title>METHODS:</jats:title> <jats:p>Subjects for this retrospective cohort study were infants born 2012–2014 at ≥35 weeks’ gestation at 1 of 17 Kaiser Permanente hospitals who underwent inpatient phototherapy before age 14 days. TSB reaching the phototherapy threshold within 72 hours of phototherapy termination was considered rebound. We simplified by using the difference between the TSB level at the time of phototherapy termination and the treatment threshold at the time of phototherapy initiation as 1 predictor, and kept GA as the other predictor.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS:</jats:title> <jats:p>Of the 7048 infants treated with phototherapy, 4.6% had rebound hyperbilirubinemia. The area under the receiver operating characteristic curve was 0.876 (95% confidence interval, 0.854 to 0.899) for the 2-variable model versus 0.881 (95% confidence interval, 0.859 to 0.903) for the 3-variable model. The rebound probability after stopping phototherapy at 2 mg/dL below the starting threshold was 2.5% for infants ≥38 weeks’ GA and 10.2% for infants &amp;lt;38 weeks’ GA.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS:</jats:title> <jats:p>Rebound hyperbilirubinemia can be predicted by a simpler 2-variable model consisting of GA and the starting threshold–ending TSB difference. Infants &amp;lt;38 weeks’ gestation may need longer phototherapy because of their higher rebound risk.</jats:p> </jats:sec> A Simpler Prediction Rule for Rebound Hyperbilirubinemia Pediatrics
spellingShingle Chang, Pearl W., Newman, Thomas B., Pediatrics, A Simpler Prediction Rule for Rebound Hyperbilirubinemia, Pediatrics, Perinatology and Child Health
title A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_full A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_fullStr A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_full_unstemmed A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_short A Simpler Prediction Rule for Rebound Hyperbilirubinemia
title_sort a simpler prediction rule for rebound hyperbilirubinemia
title_unstemmed A Simpler Prediction Rule for Rebound Hyperbilirubinemia
topic Pediatrics, Perinatology and Child Health
url http://dx.doi.org/10.1542/peds.2018-3712